Douglas A. Weigent

3.7k total citations
71 papers, 2.9k citations indexed

About

Douglas A. Weigent is a scholar working on Endocrinology, Diabetes and Metabolism, Immunology and Molecular Biology. According to data from OpenAlex, Douglas A. Weigent has authored 71 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Endocrinology, Diabetes and Metabolism, 28 papers in Immunology and 15 papers in Molecular Biology. Recurrent topics in Douglas A. Weigent's work include Growth Hormone and Insulin-like Growth Factors (30 papers), Immune Cell Function and Interaction (21 papers) and Stress Responses and Cortisol (11 papers). Douglas A. Weigent is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (30 papers), Immune Cell Function and Interaction (21 papers) and Stress Responses and Cortisol (11 papers). Douglas A. Weigent collaborates with scholars based in United States, Bulgaria and France. Douglas A. Weigent's co-authors include J. Edwin Blalock, G J Stanton, Howard M. Johnson, Marlyn P. Langford, Roger B. Fillingim, Timothy J. Ness, Keith W. Kelley, Ron Kooijman, Robert R. Edwards and Kenneth L. Bost and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and The FASEB Journal.

In The Last Decade

Douglas A. Weigent

71 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Douglas A. Weigent United States 31 860 858 524 342 338 71 2.9k
Edward W. Bernton United States 22 765 0.9× 557 0.6× 653 1.2× 414 1.2× 177 0.5× 33 2.9k
Vincent Geenen Belgium 39 1.7k 1.9× 771 0.9× 679 1.3× 343 1.0× 923 2.7× 200 4.7k
István Berczi Canada 30 880 1.0× 852 1.0× 519 1.0× 266 0.8× 326 1.0× 126 3.0k
Ν. Fabris Italy 30 745 0.9× 619 0.7× 336 0.6× 342 1.0× 267 0.8× 97 2.7k
E Sternberg United States 20 514 0.6× 591 0.7× 388 0.7× 321 0.9× 198 0.6× 37 2.7k
L. Wildt Germany 41 1.3k 1.5× 710 0.8× 672 1.3× 116 0.3× 551 1.6× 182 6.3k
Konrad Schauenstein Austria 35 709 0.8× 244 0.3× 996 1.9× 418 1.2× 242 0.7× 137 3.7k
Heinrich M. Schulte Germany 36 536 0.6× 2.2k 2.6× 841 1.6× 334 1.0× 601 1.8× 75 4.5k
Zhenmin Lei United States 43 1.3k 1.6× 900 1.0× 1.1k 2.1× 254 0.7× 1.2k 3.7× 137 5.3k
J. Raus Belgium 41 2.0k 2.4× 331 0.4× 849 1.6× 281 0.8× 300 0.9× 149 5.4k

Countries citing papers authored by Douglas A. Weigent

Since Specialization
Citations

This map shows the geographic impact of Douglas A. Weigent's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas A. Weigent with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas A. Weigent more than expected).

Fields of papers citing papers by Douglas A. Weigent

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas A. Weigent. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas A. Weigent. The network helps show where Douglas A. Weigent may publish in the future.

Co-authorship network of co-authors of Douglas A. Weigent

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas A. Weigent. A scholar is included among the top collaborators of Douglas A. Weigent based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas A. Weigent. Douglas A. Weigent is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Weigent, Douglas A.. (2013). Expression of lymphocyte-derived growth hormone (GH) and GH-releasing hormone receptors in aging rats. Cellular Immunology. 282(2). 71–78. 15 indexed citations
2.
Weigent, Douglas A.. (2013). Hypoxia and cytoplasmic alkalinization upregulate growth hormone expression in lymphocytes. Cellular Immunology. 282(1). 9–16. 9 indexed citations
3.
Weigent, Douglas A.. (2008). Regulation of Id2 expression in EL4 T lymphoma cells overexpressing growth hormone. Cellular Immunology. 255(1-2). 46–54. 4 indexed citations
4.
Kelley, Keith W., Douglas A. Weigent, & Ron Kooijman. (2007). Protein hormones and immunity. Brain Behavior and Immunity. 21(4). 384–392. 161 indexed citations
5.
Ang, Sonny, et al.. (2004). Regulation of ferrochelatase gene expression by hypoxia. Life Sciences. 75(17). 2035–2043. 50 indexed citations
6.
Edwards, Robert R., Timothy J. Ness, Douglas A. Weigent, & Roger B. Fillingim. (2003). Individual differences in diffuse noxious inhibitory controls (DNIC): association with clinical variables. Pain. 106(3). 427–437. 186 indexed citations
7.
Weigent, Douglas A., et al.. (2003). The production of nitric oxide in EL4 lymphoma cells overexpressing growth hormone. Journal of Neuroimmunology. 134(1-2). 82–94. 16 indexed citations
8.
Weigent, Douglas A., et al.. (2000). Identification of SP3 as a Negative Regulatory Transcription Factor in the Monocyte Expression of Growth Hormone*. Endocrinology. 141(3). 938–946. 11 indexed citations
9.
Weigent, Douglas A., et al.. (2000). Characterization of the Promoter-Directing Expression of Growth Hormone in a Monocyte Cell Line. NeuroImmunoModulation. 7(3). 126–134. 5 indexed citations
10.
Benfield, Mark R., et al.. (1997). Growth Hormone Induces Interferon Gamma Production and May Play a Role in the Presentation of Alloantigens in vitro. NeuroImmunoModulation. 4(1). 19–27. 5 indexed citations
11.
Rohn, Wolfgang M. & Douglas A. Weigent. (1995). Cloning and Nucleotide Sequencing of Rat Lymphocyte Growth Hormone cDNA. NeuroImmunoModulation. 2(2). 108–114. 30 indexed citations
12.
Weigent, Douglas A., Benjamin L. Clarke, & J. Edwin Blalock. (1994). Peptide Design Using a Genetically Patterned Binary Code: Growth Hormone-Releasing Hormone as a Model. PubMed. 5(2). 91–97. 14 indexed citations
13.
Law, Vincent, et al.. (1994). Effects of streptozotocin-induced diabetes on lymphocyte POMC and growth hormone gene expression in the rat. Journal of Neuroimmunology. 49(1-2). 35–44. 6 indexed citations
14.
Weigent, Douglas A., et al.. (1992). The production of growth hormone and insulin-like growth factor-I by the same subpopulation of rat mononuclear leukocytes. Brain Behavior and Immunity. 6(4). 365–376. 33 indexed citations
15.
Blalock, J. Edwin, et al.. (1991). Expression of immunoreactive growth hormone in leukocytes in vivo. Journal of Neuroimmunology. 33(1). 43–54. 23 indexed citations
16.
Weigent, Douglas A., J. Edwin Blalock, & Robert D. LeBœuf. (1991). An Antisense Oligodeoxynucleotide to Growth Hormone Messenger Ribonucleic Acid Inhibits Lymphocyte Proliferation*. Endocrinology. 128(4). 2053–2057. 67 indexed citations
17.
Weigent, Douglas A. & J. Edwin Blalock. (1990). Immunoreactive growth hormone-releasing hormone in rat leukocytes. Journal of Neuroimmunology. 29(1-3). 1–13. 48 indexed citations
18.
Carr, Daniel J.J., Douglas A. Weigent, & J. Edwin Blalock. (1989). Hormones common to the neuroendocrine and immune systems.. PubMed. 4(3). 187–95. 15 indexed citations
19.
Langford, Marlyn P., Douglas A. Weigent, Tom S. Chan, Howard M. Johnson, & G J Stanton. (1987). Antibodies to the Carboxyl Terminus of Mouse Interferon-γ Neutralize its Immunoregulatory and Antiviral Activities. Journal of Interferon Research. 7(1). 95–101. 6 indexed citations
20.
Weigent, Douglas A., Marlyn P. Langford, G J Stanton, & J. Edwin Blalock. (1984). Interferon-induced transfer of viral resistance by human B and T lymphocytes. Cellular Immunology. 87(2). 678–683. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Edward W. Bernton Breakdown of academic impact, for papers by Vincent Geenen Breakdown of academic impact, for papers by István Berczi Breakdown of academic impact, for papers by Ν. Fabris Breakdown of academic impact, for papers by E Sternberg Breakdown of academic impact, for papers by L. Wildt Breakdown of academic impact, for papers by Konrad Schauenstein Breakdown of academic impact, for papers by Heinrich M. Schulte Breakdown of academic impact, for papers by Zhenmin Lei Breakdown of academic impact, for papers by J. Raus
Rankless by CCL
2026